Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1919114

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1919114

Antacids Market Size, Share, and Growth Analysis, By Type (Calcium Carbonate, Magnesium Hydroxide), By Formulation (Tablets, Liquid / Suspension), By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 171 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Antacids Market size was valued at USD 10.2 billion in 2024 and is poised to grow from USD 10.77 billion in 2025 to USD 16.66 billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global antacids market is poised for significant growth driven by heightened awareness of GERD and the increasing availability of over-the-counter (OTC) antacid medications that provide swift relief from symptoms. The aging population, which is more vulnerable to acid-related disorders, further fuels market demand alongside rising access to dietary information. Shifts in lifestyle habits, including stress, obesity, smoking, and alcohol consumption, contribute to an upsurge in acid-related conditions, challenging healthcare providers. Additionally, the prevalence of serious conditions like Barrett's esophagus among elderly patients elevates the need for various therapeutic approaches, with antacids playing a crucial role. The ongoing popularity of OTC products highlights consumer preferences for quick solutions to heartburn and indigestion, propelling the market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antacids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antacids Market Segments Analysis

Global Antacids Market is segmented by Type, Formulation, Distribution Channel, End User and region. Based on Type, the market is segmented into Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate and Combination Antacids. Based on Formulation, the market is segmented into Tablets, Liquid / Suspension, Powder, Effervescent Granules and Gummies / Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, Online Pharmacies / E-Commerce, Supermarkets / Hypermarkets and Clinics & Healthcare Centers. Based on End User, the market is segmented into Adults, Geriatric Population, Pediatric Use and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antacids Market

One of the key market drivers for the global antacids market is the rising prevalence of gastroesophageal reflux disease (GERD) and other related gastrointestinal disorders. The increasing consumption of unhealthy diets, coupled with sedentary lifestyles, has exacerbated the incidence of acid-related conditions, leading to a greater demand for effective relief solutions. Furthermore, the growing awareness of digestive health among consumers is driving the demand for over-the-counter antacids, which provide quick and accessible relief. As healthcare providers continue to emphasize the importance of managing acid-related symptoms, the market for antacids is anticipated to witness significant growth driven by these factors.

Restraints in the Global Antacids Market

One significant market restraint for the global antacids market is the rising awareness regarding potential side effects associated with long-term use of these medications. Consumers are becoming more informed about the risks, such as kidney issues and interference with nutrient absorption, which can prompt them to seek alternative treatments or adopt lifestyle changes to manage symptoms naturally. Additionally, the increasing preference for herbal and holistic remedies is driving a shift away from conventional antacid products, thereby limiting market growth. This shift in consumer behavior poses challenges for manufacturers attempting to maintain their market share amidst growing competition from natural health solutions.

Market Trends of the Global Antacids Market

The global antacids market is witnessing a notable trend towards the increasing popularity of chewable and flavored antacid tablets. As consumers seek more enjoyable and convenient options, there is a discernible shift from traditional liquid and tablet forms to innovative chewable varieties that offer appealing flavors. This transformation caters to a broader demographic, particularly attracting younger consumers who desire products that enhance their experiences while addressing digestive discomfort. The incorporation of flavors not only masks the chalky taste often associated with antacids but also aligns with the broader consumer preference for palatable and user-friendly health solutions, driving market growth in this sector.

Product Code: SQMIG35H2402

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Technology Assessment
  • Technology Assessment
  • Regulatory Landscape

Global Antacids Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Calcium Carbonate
  • Magnesium Hydroxide
  • Aluminum Hydroxide
  • Sodium Bicarbonate
  • Combination Antacids

Global Antacids Market Size by Formulation & CAGR (2026-2033)

  • Market Overview
  • Tablets
  • Liquid / Suspension
  • Powder
  • Effervescent Granules
  • Gummies / Others

Global Antacids Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies / E-Commerce
  • Supermarkets / Hypermarkets
  • Clinics & Healthcare Centers

Global Antacids Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Adults
  • Geriatric Population
  • Pediatric Use
  • Others

Global Antacids Market Size & CAGR (2026-2033)

  • North America (Type, Formulation, Distribution Channel, End User)
    • US
    • Canada
  • Europe (Type, Formulation, Distribution Channel, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Formulation, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Formulation, Distribution Channel, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Formulation, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • GlaxoSmithKline plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Reddy's Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan (Viatris)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Consumer Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sandoz (Novartis)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zydus Cadila
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glaxo Wellcome (GSK group)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prestige Consumer Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perrigo Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!